GlassScriptPhysician profile
Edwin Golikov
NPI 1093175325
$11,871.52
in general payments reported to CMS, 2019-2025
21 companies · $2,659 in 2025
The $2,659 reported for 2025 was more than what 85% of Gastroenterology (Internal Medicine) providers received nationally (typical 2025 total: $636).
See the full distribution for Gastroenterology (Internal Medicine)
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $110 · 2020: $608 · 2021: $783 · 2022: $2,836 · 2023: $1,951 · 2024: $2,925 · 2025: $2,659.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Travel and Lodging: $5,542 · Food and Beverage: $1,993.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Travel and Lodging | $5,542.14 |
| Food and Beverage | $1,992.67 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Olympus Corporation of The Americas | $5,331.30 | 2021-2025 | Disposable Distal Attachment, Olympus, Single Use Electrosurgical Knife Kd-655 |
| Boston Scientific Corporation | $3,784.60 | 2022-2024 | Autotome Rx 49, Resolution Clip, Exalt Model D |
| Abbvie INC. | $797.47 | 2020-2023 | |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $456.36 | 2021-2025 | Xifaxan |
| Olympus America INC. | $262.50 | 2023-2024 | Visiglide, Endoclot Phs |
| Takeda Pharmaceuticals U.S.A., INC. | $238.44 | 2020-2022 | |
| Gilead Sciences, INC. | $144.35 | 2020-2025 | |
| Medtronic, INC. | $140.32 | 2022 | |
| E.R. Squibb & Sons, L.L.C. | $125.00 | 2023 | Zeposia |
| Intercept Pharmaceuticals, INC. | $123.48 | 2019-2021 | |
| Pfizer INC. | $85.72 | 2020-2021 | |
| Fujifilm Healthcare Americas Corporation | $75.00 | 2023 | |
| Phathom Pharmaceuticals, INC. | $66.71 | 2025 | Voquezna |
| Nestle Healthcare Nutrition INC. | $49.39 | 2021 | |
| Braintree Laboratories, INC. | $46.56 | 2020-2021 |
Show all 21 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Redhill Biopharma INC. | $41.44 | 2021 | |
| Novo Nordisk INC | $29.53 | 2019 | |
| Madrigal Pharmaceuticals | $23.68 | 2024 | Resmetirom |
| Alfasigma USA, INC. | $21.17 | 2020 | |
| Janssen Biotech, INC. | $16.49 | 2025 | Tremfya |
| Regeneron Healthcare Solutions, INC. | $12.01 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Edwin Golikov listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.